Academy for Sickle Cell and Thalassaemia (ASCAT 2026) 7 - 10 October 2026

Etavopivat improves hemoglobin levels in adults and adolescents with non-transfusion-dependent α- or β-thalassaemia: results from the open-label phase 2 gladiolus study

Authors :

Sujit Sheth^1*, Kevin H.M. Kuo^2,3, Theodosia A. Kalfa⁴, D. Mark Layton⁵, Perla Eleftheriou⁶, Anastasios Giakoumis⁷, Olga Polyanskaya⁸, Navid Nedjatian⁹ and Ashutosh Lal¹⁰

Affiliations

View Details Hide Details

Keywords

Thalassemia

Congress oral presentation

Etavopivat

Search Science Hub

Are you a healthcare professional?

Etavopivat improves hemoglobin levels in adults and adolescents with non-transfusion-dependent α- or β-thalassaemia: results from the open-label phase 2 gladiolus study